Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma

被引:31
|
作者
Zhou, Jun [1 ,2 ,3 ]
Li, Yanli [1 ,2 ,3 ]
Zhang, Yiqiu [1 ,2 ,3 ]
Liu, Guobing [1 ,2 ,3 ]
Tan, Hui [1 ,2 ,3 ]
Hu, Yan [1 ,2 ,3 ]
Xiao, Jie [1 ,2 ,3 ]
Shi, Hongcheng [1 ,2 ,3 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Nucl Med, Shanghai 200032, Peoples R China
[2] Fudan Univ, Nucl Med Inst, Shanghai 200032, Peoples R China
[3] Shanghai Inst Med Imaging, Shanghai 200032, Peoples R China
关键词
positron emission tomography/computed tomography; high-resolution computed tomography; lung cancer; invasive adenocarcinoma; ground-glass opacity nodule; THIN-SECTION CT; POSITRON-EMISSION-TOMOGRAPHY; LUNG ADENOCARCINOMA; BRONCHIOLOALVEOLAR CARCINOMA; FLEISCHNER-SOCIETY; FDG-PET; CANCER; CLASSIFICATION; FREQUENCY; DIFFERENTIATION;
D O I
10.18632/oncotarget.15577
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To investigate the performance of combined 18F-FDG Positron Emission Tomography/Computed Tomography with high-resolution CT for differentiating invasive adenocarcinoma from adenocarcinoma in situ (pre-invasive lesion) or minimally invasive adenocarcinoma in stage IA lung cancer patients with solitary ground-glass opacity nodules. This retrospective study enrolled 58 consecutive stage IA pulmonary adenocarcinoma patients with solitary ground-glass opacity nodules. The characteristics and measurements of the ground-glass opacity nodules as pure ground-glass opacity nodules and mixed ground-glass opacity nodules in the pre-invasive or minimally invasive adenocarcinoma and invasive adenocarcinoma groups on Positron Emission Tomography/Computed Tomography and high-resolution CT were compared and analyzed. Ground-glass opacity nodules in the pre-invasive or minimally invasive adenocarcinoma group preferentially manifested as pure ground-glass opacity nodule (p < 0.01) compared to the invasive adenocarcinoma group. While cystic appearance was more common in the invasive adenocarcinoma group (p < 0.05). Significant differences were found in the diameter of the ground-glass opacity nodule itself and its solid component, and consolidation/tumor ratio between the two groups. The sensitivity in predicting invasive adenocarcinoma was higher with a combined consolidation/tumor ratio > 0.38 and SUVmax > 1.46 in mixed ground-glass opacity nodule when compared to those of SUVmax > 0.95 alone or consolidation/tumor ratio > 0.39 alone (both p > 0.05). For a mixed ground-glass opacity nodule combined consolidation/tumor ratio > 0.38 and SUVmax > 1.46 appears to better predict invasive adenocarcinoma in stage IA lung cancer patients with solitary ground-glass opacity nodules.
引用
收藏
页码:23312 / 23321
页数:10
相关论文
共 50 条
  • [31] Application of dual-stream three-dimensional convolutional neural network based on 18F-FDG PET/CT in distinguishing benign and invasive adenocarcinoma in ground-glass lung nodules
    Shao, Xiaonan
    Niu, Rong
    Shao, Xiaoliang
    Wang, Yuetao
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [32] Application of dual-stream 3D convolutional neural network based on 18F-FDG PET/CT in distinguishing benign and invasive adenocarcinoma in ground-glass lung nodules
    Shao, Xiaonan
    Niu, Rong
    Shao, Xiaoliang
    Gao, Jianxiong
    Shi, Yunmei
    Jiang, Zhenxing
    Wang, Yuetao
    EJNMMI PHYSICS, 2021, 8 (01)
  • [33] Value of 18F-FDG PET/CT radiomic features to distinguish solitary lung adenocarcinoma from tuberculosis
    Yujing Hu
    Xinming Zhao
    Jianyuan Zhang
    Jingya Han
    Meng Dai
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 231 - 240
  • [34] Can we differentiate minimally invasive adenocarcinoma and non-invasive neoplasms based on high-resolution computed tomography features of pure ground glass nodules?
    Wang, Xiaoye
    Wang, Lihua
    Zhang, Weisheng
    Zhao, Hong
    Li, Feng
    PLOS ONE, 2017, 12 (07):
  • [35] Feasibility of Using High-Resolution Computed Tomography Features for Invasiveness Differentiation of Malignant Nodules Manifesting as Ground-Glass Nodules
    Chen, Xinyue
    Yao, Benbo
    Li, Juan
    Liang, Chunxiao
    Qi, Rui
    Yu, Jianqun
    CANADIAN RESPIRATORY JOURNAL, 2022, 2022
  • [36] Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high-resolution computed tomography-interim results
    Yoshida, Junji
    Ishii, Genichiro
    Hishida, Tomoyuki
    Aokage, Keiju
    Tsuboi, Masahiro
    Ito, Hiroyuki
    Yokose, Tomoyuki
    Nakayama, Haruhiko
    Yamada, Kouzo
    Nagai, Kanji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (07) : 677 - 681
  • [37] Quantitative CT analysis of pulmonary ground-glass opacity nodules for distinguishing invasive adenocarcinoma from non-invasive or minimally invasive adenocarcinoma: the added value of using iodine mapping
    Son, Ji Ye
    Lee, Ho Yun
    Kim, Jae-Hun
    Han, Joungho
    Jeong, Ji Yun
    Lee, Kyung Soo
    Kwon, O. Jung
    Shim, Young Mog
    EUROPEAN RADIOLOGY, 2016, 26 (01) : 43 - 54
  • [38] Quantitative CT analysis of pulmonary ground-glass opacity nodules for distinguishing invasive adenocarcinoma from non-invasive or minimally invasive adenocarcinoma: the added value of using iodine mapping
    Ji Ye Son
    Ho Yun Lee
    Jae-Hun Kim
    Joungho Han
    Ji Yun Jeong
    Kyung Soo Lee
    O. Jung Kwon
    Young Mog Shim
    European Radiology, 2016, 26 : 43 - 54
  • [39] Pulmonary nodules 10 mm or less in diameter with ground-glass opacity component detected by high-resolution computed tomography have a high possibility of malignancy
    Yoon H.-E.
    Fukuhara K.
    Michiura T.
    Takada M.
    Imakita M.
    Nonaka K.
    Iwase K.
    The Japanese Journal of Thoracic and Cardiovascular Surgery, 2005, 53 (1): : 22 - 28
  • [40] Invasive mucinous adenocarcinoma of the lung: clinicopathological features, 18F-FDG PET/CT findings, and survival outcomes
    Xiaolin Sun
    Baozhen Zeng
    Xiaoyue Tan
    Zhijian Chen
    Xiaoqiang Pan
    Lei Jiang
    Annals of Nuclear Medicine, 2023, 37 : 198 - 207